BALAXI PHARMACEUTICALS LIMITED

Healthcare

NSE: BALAXI
₹22.78
▼ -0.24 (-1.04%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
—/100
Data unavailable
Valuation
—/100
Data unavailable
Momentum
15/100
Bearish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
Data unavailable.
PE (TTM)
Data unavailable.
Price to Book
Data unavailable.
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
2.56%
FII + DII, latest filed period
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
3.5
Relative return vs Sector, qtr %
Data unavailable.
Free Cash Flow
₹15 Cr
as of Sept. 30, 2025
EPS Growth (YoY)
Data unavailable.
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
Data unavailable.
Revenue Growth (YoY)
Data unavailable.
Current Ratio
Data unavailable (needs a filed half-yearly balance sheet).
Debt to Equity
Data unavailable (needs a filed half-yearly balance sheet).
Interest Coverage
Data unavailable.
Net Margin
Data unavailable.
Operating Margin (EBIT)
Data unavailable.
Operating Margin (TTM)
Data unavailable.
Return on Assets
Data unavailable.
Return on Capital Employed
Data unavailable (needs a filed half-yearly balance sheet).
Return on Equity
Data unavailable (needs a filed half-yearly balance sheet).

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Ownership

1 of 2 met
  • No FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter

Value and momentum

0 of 4 met
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-1.0%
Low 22.5500 · High 23.4000
1W return
-0.7%
Low 21.0000 · High 23.4500
1M return
2.0%
Low 21.0000 · High 26.9900
52W return
-48.8%
Low 15.2000 · High 45.3400
Lifetime High ₹1040.1500 (Oct. 13, 2020)
Lifetime Low ₹12.9000 (Oct. 31, 2017)

Full price history and technicals →

EMA & SMA

Bullish0
Bearish6
5D
22.8
10D
23.0
20D
23.2
50D
23.5
100D
23.7
200D
23.9

Delivery and volume

Day avg. delivery
86.5%
Week avg. delivery
77.6%
Month avg. delivery
71.3%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

22.91
Pivot
First resistance23.27
Second resistance23.76
Third resistance24.12
First support22.42
Second support22.06
Third support21.57
Day RSI45.1
Day MFI34.6
Day MACD-0.23
Day MACD signal-0.17

Beta

1M0.39
3M-0.13
1Y0.87
3Y1.09

Price change analysis

↑ 2.0%
Over 1 Month
LowHigh
21.0026.99
↓ -4.0%
Over 3 Months
LowHigh
21.0026.99
↑ 21.2%
Over 6 Months
LowHigh
18.0229.90
↓ -48.8%
Over 1 Year
LowHigh
15.2045.34
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Revenue (June 30, 2026)
₹16 Cr
Net profit (June 30, 2026)
₹-1 Cr
Basic EPS (June 30, 2026)
₹

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter65.99%
  • Public31.45%

Largest holders

NameCategoryShares %Shares
BALAXI OVERSEAS PRIVATE LIMITEDPromoter63.4000%35000000
RGSL INVESTMENT FUND - RGSL INVESTMENT LVF 1Public2.5400%1400537
KUNAL MAHENDRA BHAKTAPublic1.8600%1028855
ASHISH MAHESHWARIPromoter1.6400%903870
AMOL ANAND MANTRIPublic1.4100%778176

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 65.99% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings were unchanged at 0.00% in Jun 2026 qtr

Historical mutual fund holding

All shareholding details →

Insider trading, SAST & pledges

All 27 insider trades, 13 SAST, 0 pledge events →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
15 Apr 2024 KUNAL MAHENDRA BHAKTA Director Sell 0 ₹0
15 Apr 2024 KUNAL MAHENDRA BHAKTA Director Buy 0 ₹0
18 Mar 2024 KUNAL MAHENDRA BHAKTA Director Buy 0 ₹0
18 Mar 2024 KUNAL MAHENDRA BHAKTA Director Sell 0 ₹0
18 Mar 2024 MANGINA SRINIVAS RAO Director Sell 0 ₹0
18 Mar 2024 MANGINA SRINIVAS RAO Director Buy 0 ₹0
27 Feb 2024 KUNAL MAHENDRA BHAKTA Director Sell 0 ₹0
27 Feb 2024 KUNAL MAHENDRA BHAKTA Director Buy 0 ₹0
26 Jan 2024 KUNAL MAHENDRA BHAKTA Director Sell 0 ₹0
26 Jan 2024 KUNAL MAHENDRA BHAKTA Director Buy 0 ₹0

All insider and SAST disclosures →

DateClientDealActionQuantityPriceExchange
24 Mar 2026 RGSL INVESTMENT LVF 1 Bulk Buy 522,340 17.6800 NSE
23 Mar 2026 RGSL INVESTMENT LVF 1 Bulk Buy 520,197 17.2400 NSE
31 Dec 2025 MITHUN KHAITAN Bulk Buy 420,000 27.6200 NSE
12 Dec 2025 DULCET ADVISORY PRIVATE LIMITED Bulk Buy 471,000 30.0000 NSE
12 Dec 2025 DULCET ADVISORY PRIVATE LIMITED Bulk Sell 330,564 31.8200 NSE
10 Jul 2025 DULCET ADVISORY PRIVATE LIMITED Bulk Buy 291,943 50.0200 NSE
10 Jul 2025 DULCET ADVISORY PRIVATE LIMITED Bulk Sell 4,943 50.3200 NSE
1 Jul 2025 DULCET ADVISORY PRIVATE LIMITED Bulk Buy 320,000 50.0000 NSE
4 Apr 2025 EBISU GLOBAL OPPORTUNITIES FUND LIMITED Bulk Sell 298,446 67.5000 NSE
3 Apr 2025 UNICO GLOBAL OPPORTUNITIES FUND LIMITED Bulk Sell 4,127,717 68.0000 NSE

All bulk and block deals →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
5 Aug 2026 Financial Results/Other business matters Yes
28 May 2026 Financial Results/Other business matters Yes
28 Jan 2026 Financial Results/Other business matters Yes
11 Nov 2025 Financial Results/Other business matters Yes
5 Aug 2025 Financial Results/Other business matters Yes

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

  • Down 48.8% over the past year

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about BALAXI PHARMACEUTICALS LIMITED

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.